Literature DB >> 7183735

Experimental induction of testicular teratomas in dissociated-reaggregated chimaeric gonads.

U Regenass, T D Friedrich, L C Stevens.   

Abstract

Testicular teratomas can be experimentally induced in some strains of mice by grafting 12.5-day male genital ridges to the testes of adults. The grafts develop into testes and most of them have teratomas. The cells of 12.5-day foetal gonads were dissociated and the germ cells and somatic cells were separated. When germ cells were reaggregated with somatic cells and implanted in adult testes, they formed seminiferous tubules with teratomas. The somatic cell populations were contaminated with about 1% germ cells, and when they were implanted in adult testes, they formed testes with a comparatively low incidence of teratomas. When germ cells of a highly susceptible strain were combined with somatic cells from a resistant strain, they formed chimaeric testes with a high incidence of teratomas. When germ cells from a resistant strain were combined with somatic cells from a susceptible strain they formed chimaeric gonads and the incidence of teratomas was low. This indicates that at 12.5 days the genotype of the germ cells is responsible for susceptibility. When germ cells from older foetal gonads were combined with somatic cells of 12.5-day gonads, the incidence of teratomas was low. This showed that 12.5-day somatic cells cannot 'rejuvenate' older germ cells in a way to regain their susceptibility. When 12.5-day germ cells of highly susceptible strains were combined with older somatic cells the incidence of tumours was low indicating that the age of the somatic cells influences susceptibility to teratocarcinogenesis.

Entities:  

Mesh:

Year:  1982        PMID: 7183735

Source DB:  PubMed          Journal:  J Embryol Exp Morphol        ISSN: 0022-0752


  9 in total

1.  Pluripotency takes off without Blimp1.

Authors:  Amander T Clark
Journal:  Cell Stem Cell       Date:  2012-07-06       Impact factor: 24.633

2.  A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13.

Authors:  A J Muller; A K Teresky; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 3.  The stem cell identity of testicular cancer.

Authors:  Amander T Clark
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

4.  Identification of genomic locus responsible for experimentally induced testicular teratoma 1 (ett1) on mouse Chr 18.

Authors:  Takehiro Miyazaki; Yoshie Ikeda; Ikue Kubo; Saeri Suganuma; Nastumi Fujita; Makiko Itakura; Tae Hayashi; Shuji Takabayashi; Hideki Katoh; Yukio Ohira; Masahiro Sato; Motoko Noguchi; Toshinobu Tokumoto
Journal:  Mamm Genome       Date:  2014-07-05       Impact factor: 2.957

5.  Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line.

Authors:  Anthony D Krentz; Mark W Murphy; Teng Zhang; Aaron L Sarver; Sanjay Jain; Michael D Griswold; Vivian J Bardwell; David Zarkower
Journal:  Dev Biol       Date:  2013-03-06       Impact factor: 3.582

Review 6.  What leads from dead-end?

Authors:  A Matin
Journal:  Cell Mol Life Sci       Date:  2007-06       Impact factor: 9.261

Review 7.  Instructing an embryonic stem cell-derived oocyte fate: lessons from endogenous oogenesis.

Authors:  Cory R Nicholas; Shawn L Chavez; Valerie L Baker; Renee A Reijo Pera
Journal:  Endocr Rev       Date:  2009-04-14       Impact factor: 19.871

Review 8.  The not-so-sweet side of sugar: Influence of the microenvironment on the processes that unleash cancer.

Authors:  Mam Y Mboge; Mina J Bissell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-09       Impact factor: 6.633

Review 9.  In vitro differentiation of germ cells from stem cells: a comparison between primordial germ cells and in vitro derived primordial germ cell-like cells.

Authors:  W Ge; C Chen; M De Felici; W Shen
Journal:  Cell Death Dis       Date:  2015-10-15       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.